-transparent.png){kind=logo}
OBJECTIVE Evaluate the discriminatory value of plasma interleukin-6 or C-reactive protein levels in clonal thrombocytosis compared with those in reactive thrombocytosis. METHODS A comparative analysis of quantitatively measured laboratory values in a prospectively studied group of consecutive patients. The setting was a tertiary referral center consisting of two hospitals and an outpatient clinic. Plasma interleukin-6 and C-reactive protein levels were measured in 91 consecutive patients with thrombocytosis (platelet count > or = 600 x 10(9)/L). The cause of thrombocytosis was determined by reviewing the medical histories and follow-up data without knowledge of the corresponding laboratory values. Sixty-four patients had reactive thrombocytosis, 20 had clonal thrombocytosis, and 7 had clonal thrombocytosis plus reactive thrombocytosis. Plasma interleukin-6 was measured by an enzyme-linked immunosorbent assay, and C-reactive protein was measured with rate immunonephelometry. RESULTS Interleukin-6 levels were undetectable in all the patients with clonal thrombocytosis, whereas they were increased in 60% of the patients with reactive thrombocytosis or clonal thrombocytosis plus reactive thrombocytosis. There was a correlation between interleukin-6 and C-reactive protein levels (r = .6), and the median and range values of both levels differed significantly between the clonal thrombocytosis group and the other two groups (P < 0.0001). In 81% of the patients with reactive thrombocytosis, levels of either interleukin-6 or C-reactive protein were elevated. There was no correlation between interleukin-6 and C-reactive protein levels and the platelet count. CONCLUSIONS An elevated interleukin-6 level is rare in uncomplicated clonal thrombocytosis and suggests reactive thrombocytosis. However, an isolated normal value has little discriminatory value. Measurement of C-reactive protein level may be used as a less expensive surrogate for measurement of interleukin-6. Repeatedly low levels of both interleukin-6 and C-reactive protein are most consistent with clonal thrombocytosis.
A Tefferi, and
T C Ho, and
G J Ahmann, and
J A Katzmann, and
P R Greipp
November 1995,
European journal of haematology,
A Tefferi, and
T C Ho, and
G J Ahmann, and
J A Katzmann, and
P R Greipp
May 1998,
The American journal of medicine,
A Tefferi, and
T C Ho, and
G J Ahmann, and
J A Katzmann, and
P R Greipp
October 1991,
British journal of haematology,
A Tefferi, and
T C Ho, and
G J Ahmann, and
J A Katzmann, and
P R Greipp
February 2002,
Hematology (Amsterdam, Netherlands),
A Tefferi, and
T C Ho, and
G J Ahmann, and
J A Katzmann, and
P R Greipp
August 1994,
British journal of haematology,
A Tefferi, and
T C Ho, and
G J Ahmann, and
J A Katzmann, and
P R Greipp
June 2007,
Sleep & breathing = Schlaf & Atmung,
A Tefferi, and
T C Ho, and
G J Ahmann, and
J A Katzmann, and
P R Greipp
September 2004,
American heart journal,
A Tefferi, and
T C Ho, and
G J Ahmann, and
J A Katzmann, and
P R Greipp
September 2005,
Journal of the American Geriatrics Society,
A Tefferi, and
T C Ho, and
G J Ahmann, and
J A Katzmann, and
P R Greipp
January 2006,
Scandinavian journal of clinical and laboratory investigation,
A Tefferi, and
T C Ho, and
G J Ahmann, and
J A Katzmann, and
P R Greipp
October 2006,
Genes and immunity,
